These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 27996256)
1. Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity. Rouanet-Mehouas C; Czarny B; Beau F; Cassar-Lajeunesse E; Stura EA; Dive V; Devel L J Med Chem; 2017 Jan; 60(1):403-414. PubMed ID: 27996256 [TBL] [Abstract][Full Text] [Related]
2. Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies. Nuti E; Cuffaro D; Bernardini E; Camodeca C; Panelli L; Chaves S; Ciccone L; Tepshi L; Vera L; Orlandini E; Nencetti S; Stura EA; Santos MA; Dive V; Rossello A J Med Chem; 2018 May; 61(10):4421-4435. PubMed ID: 29727184 [TBL] [Abstract][Full Text] [Related]
3. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents. Xie XW; Wan RZ; Liu ZP ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301 [TBL] [Abstract][Full Text] [Related]
4. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors. Di Pizio A; Laghezza A; Tortorella P; Agamennone M ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724 [TBL] [Abstract][Full Text] [Related]
5. Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors. Laghezza A; Luisi G; Caradonna A; Di Pizio A; Piemontese L; Loiodice F; Agamennone M; Tortorella P Bioorg Med Chem; 2020 Feb; 28(3):115257. PubMed ID: 31874775 [TBL] [Abstract][Full Text] [Related]
6. Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8. Kalva S; Vinod D; Saleena LM J Mol Model; 2014 May; 20(5):2191. PubMed ID: 24756550 [TBL] [Abstract][Full Text] [Related]
7. Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors. Campestre C; Agamennone M; Tauro M; Tortorella P Curr Drug Targets; 2015; 16(14):1634-44. PubMed ID: 25585125 [TBL] [Abstract][Full Text] [Related]
8. A bioinorganic perspective on matrix metalloproteinase inhibition. Puerta DT; Cohen SM Curr Top Med Chem; 2004; 4(15):1551-73. PubMed ID: 15579096 [TBL] [Abstract][Full Text] [Related]
9. Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivatives. Augé F; Hornebeck W; Decarme M; Laronze JY Bioorg Med Chem Lett; 2003 May; 13(10):1783-6. PubMed ID: 12729664 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors. Nara H; Sato K; Kaieda A; Oki H; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M Bioorg Med Chem; 2016 Dec; 24(23):6149-6165. PubMed ID: 27825552 [TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization and zinc binding group (ZBGs) inhibition studies on the catalytic domain of MMP7 (cdMMP7). Meng F; Yang H; Jack C; Zhang H; Moller A; Spivey D; Page RC; Tierney DL; Crowder MW J Inorg Biochem; 2016 Dec; 165():7-17. PubMed ID: 27755977 [TBL] [Abstract][Full Text] [Related]
12. Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group. Farkas E; Katz Y; Bhusare S; Reich R; Röschenthaler GV; Königsmann M; Breuer E J Biol Inorg Chem; 2004 Apr; 9(3):307-15. PubMed ID: 14762707 [TBL] [Abstract][Full Text] [Related]
13. Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach. Nara H; Kaieda A; Sato K; Naito T; Mototani H; Oki H; Yamamoto Y; Kuno H; Santou T; Kanzaki N; Terauchi J; Uchikawa O; Kori M J Med Chem; 2017 Jan; 60(2):608-626. PubMed ID: 27966948 [TBL] [Abstract][Full Text] [Related]
14. Zinc-binding groups modulate selective inhibition of MMPs. Agrawal A; Romero-Perez D; Jacobsen JA; Villarreal FJ; Cohen SM ChemMedChem; 2008 May; 3(5):812-20. PubMed ID: 18181119 [TBL] [Abstract][Full Text] [Related]
15. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors. Puerta DT; Cohen SM Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177 [TBL] [Abstract][Full Text] [Related]
16. Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis. Kalva S; Saranyah K; Suganya PR; Nisha M; Saleena LM J Mol Graph Model; 2013 Jul; 44():297-310. PubMed ID: 23938376 [TBL] [Abstract][Full Text] [Related]
17. New bifunctional metalloproteinase inhibitors: an integrated approach towards biological improvements and cancer therapy. Marques SM; Abate CC; Chaves S; Marques F; Santos I; Nuti E; Rossello A; Santos MA J Inorg Biochem; 2013 Oct; 127():188-202. PubMed ID: 23597851 [TBL] [Abstract][Full Text] [Related]
18. Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors. Choi JY; Fuerst R; Knapinska AM; Taylor AB; Smith L; Cao X; Hart PJ; Fields GB; Roush WR J Med Chem; 2017 Jul; 60(13):5816-5825. PubMed ID: 28653849 [TBL] [Abstract][Full Text] [Related]
19. Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies. Fischer T; Riedl R Int J Mol Sci; 2016 Mar; 17(3):314. PubMed ID: 26938528 [TBL] [Abstract][Full Text] [Related]
20. Identification of Non-Zinc Binding Inhibitors of MMP-2 Through Virtual Screening and Subsequent Rescoring. Shamsara J Drug Res (Stuttg); 2018 Sep; 68(9):529-535. PubMed ID: 29614516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]